Fibronectin splice variation in human knee cartilage, meniscus and synovial membrane: Observations in osteoarthritic knee

Journal of Orthopaedic Research

Volumn 33, Issue 4, 2015, Pages 556-562

  Scanzello, Carla R ^a   Markova, Dessislava Z ^b   Chee, Ana ^c   Xiu, Yan ^a   Adams, Sherrill L ^d   Anderson, Greg ^b   Zgonis, Miltiadis ^a   Qin, Ling ^a   An, Howard S ^c   Zhang, Yejia ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF PENNSYLVANIA SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

alternative splicing; cartilage; degeneration; fibronectin; synovium

Indexed keywords

BIOLOGICAL MARKER; FIBRONECTIN; RNA; ISOPROTEIN; MESSENGER RNA;

ADULT; AGED; ALTERNATIVE RNA SPLICING; ARTICLE; CARTILAGE; CARTILAGE DEGENERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; KNEE ARTHROSCOPY; KNEE MENISCUS; KNEE OSTEOARTHRITIS; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNOVIUM; ANALYSIS OF VARIANCE; ARTICULAR CARTILAGE; BIOPSY; CHEMISTRY; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; PATHOLOGY; SURGERY;

ADULT; AGED; ALTERNATIVE SPLICING; ANALYSIS OF VARIANCE; BIOPSY; CARTILAGE, ARTICULAR; FEMALE; FIBRONECTINS; HUMANS; MALE; MENISCI, TIBIAL; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PROTEIN ISOFORMS; RNA, MESSENGER; SYNOVIAL MEMBRANE;

EID: 84925687926     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22787     Document Type: Article

References (38)

1. Loeser RF, Goldring SR, Scanzello CR, et al. 2012. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 64: 1697-1707.
2. Schwarzbauer JE, Desimone DW,. 2011. Fibronectins, their fibrillogenesis, and in vivo functions. Cold Spring Harb Perspect Biol 3: a005041.
3. Magnuson VL, Young M, Schattenberg DG, et al. 1991. The alternative splicing of fibronectin pre-mRNA is altered during aging and in response to growth factors. J Biol Chem 266: 14654-14662.
4. Muro AF, Chauhan AK, Gajovic S, et al. 2003. Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan. J Cell Biol 162: 149-160.
5. Rybak JN, Roesli C, Kaspar M, et al. 2007. The extra-domain A of fibronectin is a vascular marker of solid tumors and metastases. Cancer Res 67: 10948-10957.
6. Scarpino S, Stoppacciaro A, Pellegrini C, et al. 1999. Expression of EDA/EDB isoforms of fibronectin in papillary carcinoma of the thyroid. J Pathol 188: 163-167.
7. Berndt A, Borsi L, Luo X, et al. 1998. Evidence of EDB+ fibronectin synthesis in human tissues by non-radioactive RNA in situ hybridization. Investigations on carcinoma (oral squamous cell and breast carcinoma), chronic inflammation (rheumatoid synovitis) and fibromatosis (Morbus Dupuytren). Histochem Cell Biol 109: 249-255.
8. Castellani P, Viale G, Dorcaratto A, et al. 1994. The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis. Int J Cancer 59: 612-618.
9. Gondokaryono SP, Ushio H, Niyonsaba F, et al. 2007. The extra domain A of fibronectin stimulates murine mast cells via toll-like receptor 4. J Leukoc Biol 82: 657-665.
10. Liao YF, Gotwals PJ, Koteliansky VE, et al. 2002. The EIIIA segment of fibronectin is a ligand for integrins alpha 9beta 1 and alpha 4beta 1 providing a novel mechanism for regulating cell adhesion by alternative splicing. J Biol Chem 277: 14467-14474.
11. Serini G, Bochaton-Piallat ML, Ropraz P, et al. 1998. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol 142: 873-881.
12. Mostafavi-Pour Z, Askari JA, Whittard JD, et al. 2001. Identification of a novel heparin-binding site in the alternatively spliced IIICS region of fibronectin: roles of integrins and proteoglycans in cell adhesion to fibronectin splice variants. Matrix Biol 20: 63-73.
13. Schwarzbauer JE, Spencer CS, Wilson CL,. 1989. Selective secretion of alternatively spliced fibronectin variants. J Cell Biol 109: 3445-3453.
14. MacLeod JN, Burton-Wurster N, Gu DN, et al. 1996. Fibronectin mRNA splice variant in articular cartilage lacks bases encoding the V, III-15, and I-10 protein segments. J Biol Chem 271: 18954-18960.
15. Kozaki T, Matsui Y, Gu J, et al. 2003. Recombinant expression and characterization of a novel fibronectin isoform expressed in cartilaginous tissues. J Biol Chem 278: 50546-50553.
16. Chevalier X, Claudepierre P, Groult N, et al. 1996. Presence of ED-A containing fibronectin in human articular cartilage from patients with osteoarthritis and rheumatoid arthritis. J Rheumatol 23: 1022-1030.
17. Chevalier X, Groult N, Hornebeck W,. 1996. Increased expression of the Ed-B-containing fibronectin (an embryonic isoform of fibronectin) in human osteoarthritic cartilage. Br J Rheumatol 35: 407-415.
18. Peters JH, Carsons S, Kalunian K, et al. 2001. Preferential recognition of a fragment species of osteoarthritic synovial fluid fibronectin by antibodies to the alternatively spliced EIIIA segment. Arthritis Rheum 44: 2572-2585.
19. Homandberg GA, Meyers R, Aydelotte M, et al. 1992. Isolation and characterization of an abundant elastase inhibitor from NaCl extracts of bovine nasal septa and articular cartilage. Connect Tissue Res 28: 289-305.
20. Xie D, Homandberg GA,. 1993. Fibronectin fragments bind to and penetrate cartilage tissue resulting in proteinase expression and cartilage damage. Biochim Biophys Acta 1182: 189-196.
21. Saito S, Yamaji N, Yasunaga K, et al. 1999. The fibronectin extra domain A activates matrix metalloproteinase gene expression by an interleukin-1-dependent mechanism. J Biol Chem 274: 30756-30763.
22. Muehleman C, Bareither D, Huch K, et al. 1997. Prevalence of degenerative morphological changes in the joints of the lower extremity. Osteoarthritis Cartilage 5: 23-37.
23. Outerbridge RE, Dunlop JA,. 1975. The problem of chondromalacia patellae. Clin Orthop Relat Res 110: 177-196.
24. Anderson DG, Markova D, Adams SL, et al. 2010. Fibronectin splicing variants in human intervertebral disc and association with disc degeneration. Spine 35: 1581-1588.
25. Hynes RO,. 1990. Fibronectins. New York, NY: Springer-Verlag. 546.
26. Parker AE, Boutell J, Carr A, Maciewicz RA,. 2002. Novel cartilage-specific splice variants of fibronectin. Osteoarthritis Cartilage 10: 528-534.
27. Scanzello CR, Goldring SR,. 2012. The role of synovitis in osteoarthritis pathogenesis. Bone 51: 249-257.
28. Shapiro IM, Vresilovic EJ, Risbud MV,. 2012. Is the spinal motion segment a diarthrodial polyaxial joint: what's a nice nucleus like you doing in a joint like this. Bone 50: 771-776.
29. Peters JH, Chen GE, Hynes RO,. 1996. Fibronectin isoform distribution in the mouse. II. Differential distribution of the alternatively spliced EIIIB, EIIIA, and V segments in the adult mouse. Cell Adhes Commun 4: 127-148.
30. Kriegsmann J, Berndt A, Hansen T, et al. 2004. Expression of fibronectin splice variants and oncofetal glycosylated fibronectin in the synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Rheumatol Int 24: 25-33.
31. Kaczmarek J, Castellani P, Nicolo G, et al. 1994. Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues. Int J Cancer 59: 11-16.
32. Nicolo M, Biro A, Cardillo-Piccolino F, et al. 2003. Expression of extradomain-B-containing fibronectin in subretinal choroidal neovascular membranes. Am J Ophthalmol 135: 7-13.
33. Walsh DA, McWilliams DF, Turley MJ, et al. 2010. Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis. Rheumatology (Oxford) 49: 1852-1861.
34. Ashraf S, Wibberley H, Mapp PI, et al. 2011. Increased vascular penetration and nerve growth in the meniscus: a potential source of pain in osteoarthritis. Ann Rheum Dis 70: 523-529.
35. Mapp PI, Walsh DA,. 2012. Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. Nat Rev Rheumatol 8: 390-398.
36. Borsi L, Balza E, Bestagno M, et al. 2002. Selective targeting of tumoral vasculature: comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin. Int J Cancer 102: 75-85.
37. Ashraf S, Mapp PI, Walsh DA,. 2011. Contributions of angiogenesis to inflammation, joint damage, and pain in a rat model of osteoarthritis. Arthritis Rheum 63: 2700-2710.
38. Hino K, Shiozawa S, Kuroki Y, et al. 1995. EDA-containing fibronectin is synthesized from rheumatoid synovial fibroblast-like cells. Arthritis Rheum. 38: 678-683.